Disease Diagnosis TRIZ Cases

Calculating progesterone metabolite ratios identifies pregnant females susceptible to spontaneous preterm delivery.

Sequential biomarker analysis distinguishes pneumococcal from viral meningitis, resolving diagnostic ambiguity that delays targeted treatment.

Graph-based PIRCHE prediction identifies permissible HLA mismatches, reducing analysis time and immune reaction risks in transplantation.

A blood sample exposed to a TLR4 agonist reveals specific cytokine expression levels for rapid diagnosis.

Assessing CD3 and CD8 T cell densities via Immunoscore to predict treatment response in locally advanced rectal cancer.

A diagnostic test measures specific biomarkers to predict progressive chronic renal insufficiency risk within four years.

Anti-PAD3 autoantibodies quantify disease severity and monitor treatment efficacy in rheumatoid arthritis patients.

Mass spectrometry detects specific saliva peptides to replace subjective assessments and improve chronic fatigue syndrome diagnosis reliability.

Detecting Tau and hippocalcin-1 in circulating phagocytes enables rapid neurological condition assessment via simple blood sampling.

Measuring plasma PC-O 44:4 concentrations replaces complex imaging to quantify visceral adiposity accurately.

Measuring S-methyl-L-ergothioneine enables early cystine lithiasis diagnosis, replacing invasive imaging and reducing treatment side effects.

Replacing invasive lab methods, the molecular imprinted polymer layer detects urinary spermine via capacitance shifts for rapid prostate cancer screening.

C-C chemokine 14 measurement enables early acute kidney injury diagnosis through specific biomarker detection in body fluid samples.

Dried blood spots stabilize samples for transport, resolving the trade-off between assay precision and the complexity of immediate plasma processing.

Quantifying CAAP peptides via multiplex MRM scanning differentiates infectious from non-infectious systemic inflammation.

Measuring ISG15 resolves the contradiction between diagnostic capability and cause identification in neurodegenerative diseases.

Photo-thermal imaging detects subsurface inhomogeneities missed by reflective optical readers, improving detection sensitivity.

Vaginal lipid profiles identify suitable surrogate dams, resolving low pregnancy rates in IVF procedures.

Analyzing specific gene transcripts in peripheral blood mononuclear cells predicts effective treatment selection and eliminates trial-and-error testing.

Site-directed mutations create disulfide bonds in Amadoriase, allowing cost-effective HbA1c detection without specialized chromatography equipment.

Analyzing CD14+ cell ratios differentiates glioblastoma recurrence from radiation necrosis, eliminating invasive biopsy requirements.

Quantifying CD8 and PD-L1 markers resolves low prediction accuracy for microsatellite stable solid tumors.

Immobilized capture molecules on a substrate enable selective detection of misfolded protein aggregates using fluorescent probes.

Administering a PLK4 inhibitor addresses elevated TRIM37, Chromogranin A, and Synaptophysin levels that drive cell resistance in p53-positive cancers.

Quantifying proUGN levels through immunoassays detects chronic kidney disease earlier than traditional creatinine tests.

VCAM-1 imaging probes detect biomarker expression to monitor ovarian cancer treatment response, enabling early detection of platinum resistance.

Replace invasive tissue biopsies with non-invasive blood tests measuring Pgrmc1 concentrations to monitor lung cancer progression and treatment response.

A disposable detection device uses DTNB reagent to identify thiol compounds in oral fluids through visible color changes.

Pressing the dispensing nozzle against the vessel wall prevents air bubble entrainment and eliminates stirring mechanisms for accurate blood clotting analysis.

A biomarker panel measures plasma FGF23, klotho, and erythropoietin ratios for acute kidney injury diagnosis.

An implantable medical device quantifies biomarker levels to screen patients for heart failure using a specific panel of biological markers.

A reagent kit uses a nonionic surfactant to dissociate serum amyloid A from high-density lipoprotein for immunological measurement.

Cervicovaginal lavage samples detect immune checkpoint proteins and microbiota to predict immunotherapy response without invasive biopsies.

Quantifying free kappa and lambda immunoglobulin chains in blood samples provides an objective diagnostic tool for psychiatric disorders.

Measuring estradiol esters in follicular fluid or plasma evaluates oocyte quality, resolving the trade-off between invasive sampling and accurate prediction.

A composite biomarker panel assesses innate and adaptive serum mediators to generate a risk score for systemic lupus erythematosus onset.

Detecting liver-derived exosomes using antibodies targeting ASGPR1 and PD-L1 proteins for precise biomarker quantification.

Random Forest model analyzes blood biomarkers to predict patient response to TNFα blocking agents, avoiding ineffective treatments and side effects.

Superantigen stimuli accelerate cytokine production in blood samples, enabling accurate infection risk prediction within seven days.

Combining multiple biomarkers into a single diagnostic signature improves early detection accuracy and specificity for pancreatic cancer.

Anti-LG3 antibody levels predict acute vascular rejection risk in transplant recipients.

Fluorescent nanodiamond particles bind to activated platelet receptors to detect blood clots via optical emission.

Portable device detects blood glucose and proteins via electrochemical sensors to determine insulin resistance status.

A portable device measures neutrophil gelatinase-associated lipocalin levels in bodily fluids to provide objective injury severity data.

Calculating the NT-proANP to NT-proBNP ratio enables reliable differentiation between stroke and transient ischemic attacks, preventing delayed intervention.

Whole blood impedance measurement determines coagulation abnormalities through area under the curve analysis, eliminating centrifugation and multiple reagents.

HPLC-tandem mass spectrometry differentiates kisspeptin-54 forms by segmenting detection into precursor and fragment ion stages.

A computerized system analyzes laryngeal cell samples using image recognition to detect inflammatory markers and generate diagnostic scores.